Mission
Through AI-driven Innovation:
- Transform the cancer patient journey.
- Completely revolutionize the research output lifecycle.
Founded in 2025, Oncogen.AI was established by clinical physicians, oncology experts, AI scientists, and product designers united by a shared mission to advance the intelligent transformation of cancer care. Powered by Agentic AI, our platform transforms the fragmented and complex workflows of oncology into collaborative, continuously learning intelligent systems. This enables every participant in the cancer journey—from physicians, nurses, and case managers to patients—to experience a precise, organized, and personalized smart-care environment, even in the most demanding clinical settings.
Through AI-driven Innovation:
The leading brand for smart assistants in Precision Medicine and Research.
2021
2022
2023
2024
2025
October
Multi-Module Clinical Decision Support System-Shared Decision Making
December
Pathological classification of Lung cancer types using annotation-free whole slide training approach deep learning method
December
Lung Cancer Clinical Decision Support System-Shared Decision Making gnosis and Screen Global Clinical Trials for Advanced Lung Cancer.
October
Using Generative Deep Learning to Predict the Efficacy Prognosis and Screen Global Clinical Trials for Advanced Lung Cancer.
October
December
Generative AI-assisted drug selection Mobile system for NGS genetic testing
June
October
OncoDT Oncology Digital Twin
December
AI Radiology Reporting Agent
December
Molecular Tumor Board AI Agent System